Edwards Lifesciences (EW) Announces Expanded Indication From FDA for SAPIEN 3 Transcatheter Heart Valve
Go back to Edwards Lifesciences (EW) Announces Expanded Indication From FDA for SAPIEN 3 Transcatheter Heart Valve| Edwards Lifesciences (NYSE: EW) | Delayed: 88.61 +0.86 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.75 | 52 Week High | $166.87 | |||
| Open | $87.88 | 52 Week Low | $72.20 | |||
| Day High | $89.17 | P/E | 25.76 | |||
| Day Low | $87.70 | EPS | $3.44 | |||
| Volume | 2,532,260 | |||||
